Our website uses cookies to give you an improved user experience. By continuing to use this site, you agree to us using cookies as outlined in our Cookie Policy, where you can also find out how to change your settings.
AgreeLatest news
Displaying 121 - 125 of 208
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
-
Petition for Abraxane to stay on CDF presented to House of Commons
Mon 20 July 2015Nic Dakin MP will tomorrow (Tuesday 21st July) present to the House of Commons a petition, signed by over 2,700 people, calling for a life-extending drug to remain available to patients with advanced pancreatic cancer in England through the Cancer Drugs Fund (CDF).Read More about 'Petition for Abraxane to stay on CDF presented to House of Commons'
-
New research into the spread of pancreatic cancer begins at University of Southampton
Tue 14 July 2015New research into the spread of cancerous cells, funded by Pancreatic Cancer UK, PLANETS Charity and the Masonic Samaritan Fund, is under way at the University of Southampton.Read More about 'New research into the spread of pancreatic cancer begins at University of Southampton'
-
Comment on new NICE Referral Guidelines for Suspected Cancer
Tue 23 June 2015Today the National Institute for Health and Care Excellence (NICE) has published new Referral Guidelines for Suspected Cancer. David Park, Head of Policy and Campaigns at Pancreatic Cancer UK, comments.Read More about 'Comment on new NICE Referral Guidelines for Suspected Cancer'
-
Sir John Hurt diagnosed with pancreatic cancer
Tue 16 June 2015Actor Sir John Hurt has been diagnosed with pancreatic cancer. We are grateful for his openness in talking about the disease and his treatment.Read More about 'Sir John Hurt diagnosed with pancreatic cancer'
-
Life-extending pancreatic cancer drug's availability long-term "on a knife edge"
Mon 01 June 2015NICE may not recommend a life-extending drug for long-term use on the NHS in England.Read More about 'Life-extending pancreatic cancer drug's availability long-term "on a knife edge"'